hyoscyamine has been researched along with ici 204,219 in 1 studies
| Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (ici 204,219) | Trials (ici 204,219) | Recent Studies (post-2010) (ici 204,219) |
|---|---|---|---|---|---|
| 99 | 1 | 55 | 463 | 101 | 91 |
| Protein | Taxonomy | hyoscyamine (IC50) | ici 204,219 (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 9.7 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 5.751 | |
| Adenosine receptor A3 | Homo sapiens (human) | 1.363 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.2575 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.363 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.81 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 4.376 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.538 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 2 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.363 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 6.5 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.353 | |
| Cysteinyl leukotriene receptor 1 | Cavia porcellus (domestic guinea pig) | 0.002 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.3 | |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 7.397 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.0039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for hyoscyamine and ici 204,219
| Article | Year |
|---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |